IKTOS
Incorporated in October 2016, Iktos is a start-up company specializing in the development of artificial intelligence solutions applied to chemical research, more specifically medicinal chemistry and new drug design. Iktos is developing a proprietary and innovative solution based on deep learning generative models, which enables, using existing data, the design of molecules that are optimized in silico to meet all the success criteria of a small molecule discovery project. The use of Iktos techno... logy enables major productivity gains in upstream pharmaceutical R&D. Iktos offers its technology both as a professional services and as a SaaS software platform. Iktos offers Makya™, ligand and structure-based de novo drug design platform for multi-parametric optimisation (MPO) of lead compounds in line with Target Candidate Profile (TCP). Iktos is also developing Spaya™, a synthesis planning software based upon Iktos’s proprietary AI technology for retrosynthesis.
IKTOS
Industry:
Artificial Intelligence Biotechnology Chemical Health Care Machine Learning Pharmaceutical
Founded:
2016-10-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.iktos.ai
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Employees Featured
Founder
Investors List
AGORANOV
AGORANOV investment in Non Equity Assistance - Iktos
Official Site Inspections
http://www.iktos.ai Semrush global rank: 5.55 M Semrush visits lastest month: 1.53 K
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Iktos"
Iktos - Crunchbase Company Profile & Funding
Iktos is a French scale-up company specializing in artificial intelligence and robotic solutions applied to research in medicinal chemistry and new drug …See details»
iktos - LinkedIn
Iktos has also developed Iktos Robotics, a unique AI-driven synthesis automation platform that dramatically accelerates the Design-Make-Test-Analyze cycle in drug discovery and is developing its ...See details»
Iktos 2025 Company Profile: Valuation, Funding & Investors
The company's platform specializes in artificial intelligence and robotic solutions applied to research in medicinal chemistry and new drug design, applied to chemical research, …See details»
Iktos | EuroQuity
About your organization / profile Iktos is a global leader in artificial intelligence and robotics for drug discovery. Its generative AI technology designs molecules in silico, optimized to meet all …See details»
This French startup scores €15.5M funding to speed up drug …
Mar 10, 2023 A French startup specialising in AI for new drug discovery, Iktos, has scored €15.5 million in Series A funding. The investment round was co-led by new investors M Ventures and …See details»
How Iktos Wants To Revolutionize Drug Discovery …
Nov 15, 2024 In the race to accelerate drug discovery through artificial intelligence, French startup Iktos has emerged as a pioneer in Europe, developing an integrated platform that combines generative AI, automated synthesis, and …See details»
Iktos - M Ventures
Iktos develops artificial intelligence (AI) solutions for the drug discovery and new drug design. Iktos’ proprietary and innovative technology is based on generative deep learning models, …See details»
Iktos - Funding, Financials, Valuation & Investors - Crunchbase
Iktos is a deep learning technology platform focused on new drug design and discovery. ... Experience the new Crunchbase, powered by AI . Experience the new Crunchbase, powered …See details»
Iktos - Debiopharm
Iktos is an innovative company specializing in the development of artificial intelligence (AI) solutions applied to chemical research, more specifically medicinal chemistry and new drug design. The use of Iktos technology …See details»
Iktos Company Profile - Office Locations, Competitors, Revenue
Iktos is a company developing an artificial intelligence technology for ligand-based drug design, focusing on MPO (multi-parametric optimization). Its proprietary algorithm is based on deep …See details»
Latest News - Iktos
Oct 17, 2024 Subscribe to our newsletter to receive the latest updates on AI-driven drug discovery from Iktos. Subscribe. Contact Us : 65 rue de Prony, 75017 Paris, France. Tél. : 09 …See details»
Iktos Company Profile: AI, Investments, Contact Information, News ...
Iktos is a French start-up company which develops a truly innovative and disruptive artificial intelligence technology for ligand and structure-based de novo drug design.Our innovative …See details»
About - Iktos
PhD in Artificial Intelligence. Several years experience in software development and R&D. Contributed to the emerging data science field by creating distributed computation platform for …See details»
Iktos - AI for Healthcare Hub
The company has also ventured into robotics with Iktos Robotics, an automated synthesis platform that integrates AI for molecular design with robotic experimentation. Iktos' technology …See details»
Iktos - futureTEKnow Company Profile
Iktos is a company that uses artificial intelligence (AI) and robotics to streamline the process of drug discovery.See details»
This Open-Source Company Is Quietly Working To Transform AI
1 day ago A few short years ago, decentralized artificial intelligence was a fringe concept — a speculative side path compared to the centralized AI juggernauts such as OpenAI, Google …See details»
Iktos Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Iktos. See Iktos company profile and funding data.See details»
AI-Driven Organizational Structure for Successful AI Transformation
Mar 28, 2025 Implementing an AI transformation demands rethinking traditional organizational structures. Successful AI teams require autonomy, flexibility, iterative practices, and extensive …See details»
Drug Discovery Collaborations - iktos.ai
Partner with Iktos to identify your next preclinical candidate in less than two years ... Subscribe to our newsletter to receive the latest updates on AI-driven drug discovery from Iktos. Subscribe. …See details»
How COOs maximize operational impact from gen AI and agentic AI
Mar 20, 2025 To an even greater degree than seen in earlier waves of technology-based transformation, gen AI touches virtually every part of a business organization. This expanded …See details»